Shopping Cart

Imagion Biosystems Secures Nanoparticle Manufacturer

Imagion Biosystems Secures Nanoparticle Manufacturer

ChemConnection announcement imageImagion Biosystems Limited (Imagion, ASX:IBX) has entered into a Master Service Agreement with ChemConnection BV, a Dutch contract manufacturing organization (CMO) to produce and supply clinical-grade MagSense® nanoparticle formulations for the Company’s planned HER2 breast cancer human clinical studies.
View the ASX announcement, “Imagion Biosystems Secures Nanoparticle Manufacturer.”

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.